The COPD therapeutics market presents opportunities in integrated care and digital advancements. Rising disease prevalence ...
Please provide your email address to receive an email when new articles are posted on . Available studies on wearable devices and COPD exacerbations have differing data collection methods. Patient ...
), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. The Food and Drug Administration (FDA) recently cleared ResMed's home ...
The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...
DEAR DR. GOTT: My father, age 93, suffers from chronic obstructive pulmonary disease (COPD). I have read about a device called a “lung flute.” Can this device be used to help break up mucus and clear ...
The global aerosol delivery devices market size was US$ 14.5 billion in 2021. The global aerosol delivery devices market is forecast to grow to US$ 21.1 billion by 2030 by growing at a compound annual ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback